Comparisons10 min readUpdated 2026-08-28

    AltRx vs TrimRx: Are They the Same Company? (2026 Comparison)

    No, they are two separate compounded GLP-1 telehealth services. AltRx lists compounded semaglutide at $89/mo and tirzepatide at $149/mo; TrimRx charges $199/mo and $349/mo. Here is how they actually differ, and where a third option fits at $99-$125/mo.

    Quick answer

    AltRx and TrimRx are not the same company. AltRx (altrx.com) is operated by Trinity HealthCare Supply, LLC, with medical care through OpenLoop Healthcare Partners, PC, and lists compounded semaglutide at $89/mo and compounded tirzepatide at $149/mo. TrimRx (trimrx.com) is a separate platform that lists $199/mo and $349/mo, all-inclusive.

    AltRx has the lower list prices and names its four 503A pharmacy partners; TrimRx publishes a flat all-inclusive model but does not name its pharmacies on its pricing pages. Both are self-pay, and in both cases the compounded medication is prepared per individual prescription by a state-licensed pharmacy and is not FDA-approved as a drug. Individual results vary.

    About this comparison

    Written by the Trimi Medical Team. Medically reviewed by Dr. Sean Arora, MD. Updated August 28, 2026. AltRx figures were taken from altrx.com product and about pages, and TrimRx figures from trimrx.com's published pricing guides. Competitor pricing estimates were last verified August 2026; both companies can change rates and terms at any time, so verify current pricing directly with each provider. Trimi (trytrimi.com) publishes this guide and is a competing compounded GLP-1 service; we have kept the AltRx and TrimRx sections factual and sourced so you can check every claim yourself.

    No, AltRx and TrimRx Are Not the Same Company

    The confusion is understandable. Both names follow the same telehealth formula, a weight-related word plus "Rx," both sell compounded GLP-1 medications through an online visit, and both ship from compounding pharmacies. But they are distinct businesses with different operators, different clinical networks, different pharmacy partners, and very different prices.

    AltRx is the consumer brand of Trinity HealthCare Supply, LLC. The company is explicit that it is a technology and administrative platform: it does not employ healthcare providers or practice medicine. Medical services are delivered through OpenLoop Healthcare Partners, PC and its affiliated practices, and prescriptions are filled by four named state-licensed 503A compounding pharmacies: RedRock Pharmacy (Utah), Health Warehouse (Kentucky), Precision Medicine (New York), and Triad Rx (Alabama). AltRx lists compounded semaglutide at $89/mo and compounded GLP-1/GIP (tirzepatide) at $149/mo; across its lineup it offers both injectable and oral formulations, though the $149 tirzepatide product is a once-weekly injection. Typical processing and delivery is roughly 4-5 business days.

    TrimRx operates independently at trimrx.com. Its published pricing guides list compounded semaglutide at $199/mo and compounded tirzepatide at $349/mo, with the provider consultation, medication, and shipping bundled into the monthly price and no added fees for dose adjustments. TrimRx states it works exclusively with FDA-registered compounding pharmacies, though it does not name them on its pricing pages. We cover the platform in depth in our TrimRx legitimacy review and TrimRx cost breakdown.

    Nothing on either company's site indicates shared ownership. Different operating entities, different clinical partners, different pharmacies, different prices: two separate companies that happen to sound alike. And to complete the name-collision picture, Trimi, the company publishing this page, is a third, unrelated business that readers also mix up with TrimRx.

    Comparing compounded GLP-1 services? Trimi is $99/mo semaglutide, $125/mo tirzepatide

    Trimi's annual plan is all-inclusive: medication, a licensed provider through the Arora Health 50-state network, and free overnight shipping once compounded. Dispensed by 503A pharmacies VialsRx (Texas State Board of Pharmacy #35264) and GreenwichRx. The annual plan is a 12-month commitment backed by a 6-month money-back promise. Compounded preparations are prepared per individual prescription and are not FDA-approved as drugs; a licensed provider determines eligibility.

    AltRx vs TrimRx: Side-by-Side

    Everything below comes from each company's own public pages as of August 2026. Where a company does not publish a detail, we say so rather than guess.

    Operating company

    AltRx
    Trinity HealthCare Supply, LLC (d/b/a altRx)
    TrimRx
    TrimRx, a separate telehealth platform (trimrx.com)

    Compounded semaglutide

    AltRx
    $89/mo (listed Aug 2026)
    TrimRx
    $199/mo (listed Aug 2026)

    Compounded tirzepatide

    AltRx
    $149/mo (listed Aug 2026)
    TrimRx
    $349/mo (listed Aug 2026)

    What the price includes

    AltRx
    Telehealth consultations, care plan, prescription fulfillment if appropriate, shipping
    TrimRx
    Medication, provider consultation, and shipping; no added fees for dose adjustments

    Clinical model

    AltRx
    Licensed providers via OpenLoop Healthcare Partners, PC
    TrimRx
    Licensed telehealth providers on the TrimRx platform

    Compounding pharmacies

    AltRx
    Four named 503A pharmacies: RedRock (UT), Health Warehouse (KY), Precision Medicine (NY), Triad Rx (AL)
    TrimRx
    States it uses FDA-registered compounding pharmacies; partners not individually named on its pricing pages

    Medication formats

    AltRx
    Injectable and oral formulations across its lineup (the tirzepatide product is a once-weekly injection)
    TrimRx
    Injectable; its pricing guide notes compounded semaglutide typically comes in vials

    Insurance

    AltRx
    Self-pay, no insurance required
    TrimRx
    Self-pay, all-inclusive monthly price

    The headline difference is price: AltRx's listed rates are $110/mo lower for semaglutide and $200/mo lower for tirzepatide. The structural difference is disclosure. AltRx names its four compounding pharmacies and its clinical entity on its own site, which makes independent verification straightforward. TrimRx describes its pharmacies only as FDA-registered, so verifying the actual dispensing pharmacy takes an extra step, usually asking support directly or checking the label on your first shipment.

    Whichever service you consider, the verification habit is the same. Our guide to checking a compounding pharmacy's 503A license walks through confirming a state pharmacy license in under five minutes.

    What "AltRx Reviews" Should Actually Check

    If you searched for AltRx reviews, you are really asking whether the service is safe and worth the money. Star ratings answer neither. For any compounded GLP-1 telehealth service, four checks matter more than testimonials:

    • Named, verifiable pharmacies. AltRx passes this test: RedRock, Health Warehouse, Precision Medicine, and Triad Rx are all listed publicly, and each state board of pharmacy lets you confirm the license yourself.
    • A real clinical entity. AltRx discloses that OpenLoop Healthcare Partners, PC provides its medical care, and states plainly that a prescription is never guaranteed, which is what a legitimate provider-led model looks like.
    • Honest compounding disclosure. AltRx states its compounded medications have not been evaluated by the FDA for safety, efficacy, or quality. Any service that hides or hedges this disclosure is a red flag.
    • All-in cost over 12 months. A $89/mo list price and a $199/mo list price can converge or diverge depending on dose changes, fees, and plan terms. Multiply out a full year before comparing.

    On those structural checks, AltRx presents as a transparent operation. What we cannot verify from public pages, and what you should confirm directly before paying, are cancellation terms, refund policy, and how pricing behaves if your dose changes.

    The Third Option: How Trimi Compares to Both

    Since you are already comparing compounded GLP-1 services, here is the honest three-way picture. Trimi's annual plan undercuts TrimRx on both medications and undercuts AltRx on tirzepatide; AltRx's $89/mo semaglutide list price is $10/mo below Trimi's. What Trimi adds for that $10 is a named two-pharmacy supply chain, a 50-state clinician network, free overnight shipping once compounded, and a 6-month money-back promise on a plan whose price is flat at every dose.

    Trimi

    Semaglutide
    $99/mo
    Tirzepatide
    $125/mo
    Plan
    Annual plan (12-month commitment) with a 6-month money-back promise
    Pharmacies
    VialsRx (TX Board of Pharmacy #35264) + GreenwichRx, both 503A
    Clinical
    Arora Health 50-state provider network

    AltRx

    Semaglutide
    $89/mo
    Tirzepatide
    $149/mo
    Plan
    Self-pay membership; confirm plan terms at enrollment
    Pharmacies
    RedRock, Health Warehouse, Precision Medicine, Triad Rx (503A)
    Clinical
    OpenLoop Healthcare Partners, PC

    TrimRx

    Semaglutide
    $199/mo
    Tirzepatide
    $349/mo
    Plan
    Monthly, all-inclusive; confirm plan terms at enrollment
    Pharmacies
    FDA-registered compounding pharmacies (not individually named)
    Clinical
    Platform telehealth providers

    Trimi was founded in May 2024, is headquartered in New York City, and runs the same regulatory model as AltRx and TrimRx: an online intake reviewed by a licensed provider, with medication prepared per individual prescription by a state-licensed 503A pharmacy. The compounded preparations are not FDA-approved as drugs, and a licensed provider, not the website, decides whether treatment is appropriate for you.

    On effectiveness, all three services prescribe medications in the same two drug classes, and the published efficacy data comes from trials of the FDA-approved products rather than from any compounded preparation. Clinical trials show a 20.9% average body-weight reduction with tirzepatide at the 15 mg dose over 72 weeks, according to the 2022 SURMOUNT-1 study in the New England Journal of Medicine, and a 14.9% average with semaglutide over 68 weeks in the 2021 STEP 1 trial. Compounded preparations have not been studied in trials of their own, and individual results vary.

    For a wider field than these three, our TrimRx alternatives comparison covers five providers on all-in price and plan terms, and our compounded tirzepatide cost guide breaks down what an all-inclusive monthly price should include. Already a TrimRx member? The switching guide covers how to change providers without a gap in treatment.

    Frequently Asked Questions

    Are AltRx and TrimRx the same company?

    No. AltRx (altrx.com) is operated by Trinity HealthCare Supply, LLC, with medical services delivered through OpenLoop Healthcare Partners, PC. TrimRx (trimrx.com) is a separate telehealth platform with its own pricing, providers, and pharmacy relationships. They share nothing but the '-Rx' naming pattern that is common across telehealth weight loss brands.

    Which is cheaper, AltRx or TrimRx?

    As of August 2026, AltRx lists compounded semaglutide at $89/month and compounded tirzepatide at $149/month, while TrimRx lists $199/month for compounded semaglutide and $349/month for compounded tirzepatide, all-inclusive. List price is only part of the picture: confirm what each membership includes, any plan commitments, and current rates directly with each provider before enrolling.

    Is AltRx legitimate?

    AltRx publicly names its four state-licensed 503A compounding pharmacy partners (RedRock Pharmacy, Health Warehouse, Precision Medicine, and Triad Rx) and discloses that its compounded medications are not FDA-approved, both marks of a transparent operation. As with any compounded GLP-1 service, verify the dispensing pharmacy's state license yourself and confirm a licensed provider reviews your health history before anything is prescribed.

    Is TrimRx legitimate?

    TrimRx is a real, separate telehealth platform. It states that it works with FDA-registered compounding pharmacies and bundles the provider consultation, medication, and shipping into one monthly price, with no added fees for dose adjustments ($199/mo semaglutide, $349/mo tirzepatide as of August 2026). Our separate TrimRx review covers the five things worth checking before you enroll.

    Is Trimi the same as TrimRx?

    No. Trimi (trytrimi.com) is a third, unrelated company, founded in May 2024 and headquartered in New York City. Trimi offers compounded semaglutide at $99/month and compounded tirzepatide at $125/month on the annual plan, a 12-month commitment backed by a 6-month money-back promise, with medication dispensed by VialsRx (Texas State Board of Pharmacy #35264) and GreenwichRx.

    Do AltRx or TrimRx take insurance?

    Both are self-pay programs. Compounded GLP-1 medications are generally not covered by insurance because compounded preparations are not FDA-approved drugs. Trimi is also self-pay. Some patients use HSA/FSA funds; confirm eligibility with your plan administrator.

    How much weight do people lose on GLP-1 medications?

    Clinical trials of the FDA-approved products reported a 20.9% average body-weight reduction with tirzepatide at the 15 mg dose over 72 weeks (SURMOUNT-1, 2022) and 14.9% with semaglutide over 68 weeks (STEP 1, 2021). Compounded preparations have not been studied in clinical trials of their own, and individual results vary.

    Who qualifies for compounded GLP-1 treatment?

    A licensed provider makes that determination after reviewing your health history, weight, and current medications during the online intake. No reputable service guarantees a prescription: AltRx states explicitly that a prescription is never guaranteed, and at Trimi the prescribing decision likewise rests entirely with the licensed provider.

    Compare for Yourself

    Compounded semaglutide $99/mo, tirzepatide $125/mo on Trimi's annual plan

    All-inclusive, same price at every dose, free overnight shipping once compounded, 6-month money-back promise. A licensed provider reviews every intake; individual results vary.

    Start your online visit

    Sources & References

    1. AltRx product and about pages (altrx.com), pricing, pharmacy partners, and clinical model, accessed August 2026.
    2. TrimRx published pricing guides (trimrx.com), accessed August 2026.
    3. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216 (SURMOUNT-1).
    4. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002 (STEP 1).
    5. FDA prescribing information for approved semaglutide and tirzepatide products (side effect and boxed-warning profile).

    Medical Disclaimer: This article is informational and not medical advice. Semaglutide and tirzepatide are prescription GLP-1 medications. Per FDA prescribing information for the approved products, common side effects include nausea, vomiting, and diarrhea; serious risks include pancreatitis, gallbladder disease, acute kidney injury, and a boxed warning for thyroid C-cell tumors observed in rodent studies, making these medications contraindicated for people with a personal or family history of medullary thyroid carcinoma or MEN 2. Compounded semaglutide and tirzepatide are prepared per individual prescription by state-licensed compounding pharmacies and are not FDA-approved as drugs. Individual results vary. A licensed provider determines whether treatment is appropriate for you; always consult a licensed clinician before starting, changing, or stopping any medication.

    What does the current clinical evidence support for GLP-1-based weight management?

    GLP-1 receptor agonists (semaglutide, tirzepatide) have Phase 3 RCT evidence for chronic weight management in adults with BMI ≥30 or BMI ≥27 with a weight-related comorbidity. Trimi offers compounded semaglutide at $99/month and compounded tirzepatide at $125/month on the annual plan, prepared per individual prescription by 503A community sterile compounding pharmacies and reviewed by a US-licensed clinician through Arora Health's 50-state provider network. Compounded preparations are not themselves FDA-approved as drugs. Eligibility is determined by a licensed clinician.

    Phase 3 RCT evidence base: STEP 1 (NEJM 2021), SURMOUNT-1 (NEJM 2022), SELECT (NEJM 2023), FLOW (NEJM 2024)
    Trimi pricing: $99/month semaglutide / $125/month tirzepatide on annual plan
    Clinical review: Dr. Sean Arora, MD via Arora Health 50-state network

    Key Takeaways

    • Compounded semaglutide and compounded tirzepatide are prepared per individual prescription by 503A community sterile compounding pharmacies (VialsRx, Texas State Board pharmacy license #35264, and GreenwichRx). The active ingredients (semaglutide, tirzepatide) are FDA-approved in the corresponding brand finished products (Wegovy / Ozempic and Zepbound / Mounjaro respectively). Compounded preparations are not themselves FDA-approved as drugs.
    • Eligibility for GLP-1 treatment is determined by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal/family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Most are mild-to-moderate and concentrated during dose escalation. Severe gastrointestinal symptoms causing dehydration can increase acute kidney injury risk and should be reported to the prescribing clinician.
    • Trimi's clinical review is coordinated by Dr. Sean Arora, MD through Arora Health's 50-state provider network. Trimi pricing: $99/month for compounded semaglutide and $125/month for compounded tirzepatide on the annual plan; flat across all prescribed doses within whichever plan, with no enrollment / consultation / shipping fees.
    • This is general information based on the cited sources, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: August 28, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Really great customer service! Fast shipment.

    Outcome: Fast shipment

    - Amy K.Facebook
    Just recieved my order today. I placed order Monday afternoon and arrived this afternoon. Everything packaged great, clear instructions to follow. The customer service was excellent. I have tried other companies, but this is the most affordable by far. I am almost at my goal weight.

    Outcome: Next-day arrival; most affordable tried; near goal weight

    - Raquel R.Facebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Garvey WT, Mechanick JI, Brett EM, et al. (2024). American Association of Clinical Endocrinology / American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice.Read StudyDOI: 10.4158/EP161365.GL
    2. American Heart Association (2021). Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation.Read StudyDOI: 10.1161/CIR.0000000000000973
    3. Apovian CM, Aronne LJ, Bessesen DH, et al. (2015). Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism.Read StudyDOI: 10.1210/jc.2014-3415

    Was this article helpful?

    Keep Reading

    Complete guide covering brand-name versus compounded GLP-1 medication safety in 2026. Compare options, understand pricing, and discover how compounded GLP-1 medications are prescribed and dispensed through licensed telehealth.

    Clinician-reviewed guide to tirzepatide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded tirzepatide option compares.

    Compare new GLP-1 medications to legacy phentermine, mechanism, results, safety.

    Found weight loss review for 2026: how the coaching plus medication program works, $199 to $349/mo all-in GLP-1 costs, who it fits, and who should skip it.

    Compounded GLP-1 from $99/mo annual plan; results vary.

    Start visit

    Start your GLP-1 journey, from $99/mo

    Get Started